HEPHAISTOS-Pharma
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 Rue Jean Rostand, Orsay, Ile-de-France...Website
www.hephaistos-pharma.frRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About HEPHAISTOS-Pharma
HEPHAISTOS-Pharma is a preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers. The company is headquartered in Orsay, Ile-de-France, France.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HEPHAISTOS-Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on HEPHAISTOS-Pharma recently announced quarterly report
Product Launch: Get notified when HEPHAISTOS-Pharma launches new products
Click to see if HEPHAISTOS-Pharma had a recent Job posting/layoffs
Check out if HEPHAISTOS-Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at HEPHAISTOS-Pharma
Check if HEPHAISTOS-Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once HEPHAISTOS-Pharma has new funding data
HEPHAISTOS-Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined HEPHAISTOS-Pharma as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
HEPHAISTOS-Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HEPHAISTOS-Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HEPHAISTOS-Pharma.
HEPHAISTOS-Pharma financials insights
Gather financial insights about HEPHAISTOS-Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$13.1M
HEPHAISTOS-Pharma Tech Stack
A closer look at the technologies used by HEPHAISTOS-Pharma
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Funding
Funding
Funding
HEPHAISTOS-Pharma News & Media
HEPHAISTOS secures €10.3 M to reach the clinical stage
PR: HEPHAISTOS secures €10.3 M to reach the clinical stageHEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq
HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HEPHAISTOS-Pharma
Sign Up For FreeTo access detailed company insights
HEPHAISTOS-Pharma is a preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers. The company is headquartered in Orsay, Ile-de-France, France.... Read More
